A new type of sleep medication, ramelteon, was approved in 2005
by the FDA. It acts on the receptors for melatonin, which
contributes to regulating the body's circadian rhythms.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.